Synthesis and evaluation of 2′-deoxy-2′-18F-fluoro- 5-fluoro-1-β-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression

Journal of Nuclear Medicine

Volumn 45, Issue 12, 2004, Pages 2063-2069

  Alauddin, Mian M ^a   Shahinian, Antranic ^a   Park, Ryan ^a   Tohme, Michel ^a   Fissekis, John D ^a   Conti, Peter S ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

2 deoxy 2 18F fluoro 5 fluoro 1 D arabinofuranosyluracil; Gene expression; Herpes simplex virus type 1 thymidine kinase; HT 29 cells; PET

Indexed keywords

2' DEOXY 2' FLUORO 5 FLUORO 1 BETA DEXTRO ARABINOFURANOSYLURACIL F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2' DEOXY 2' 18F FLUORO 5 FLUORO 1 BETA D ARABINOFURANOSYLURACIL; 2'-DEOXY-2'-18F-FLUORO-5-FLUORO-1-BETA-D-ARABINOFURANOSYLURACIL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUOROURACIL; THYMIDINE KINASE; URACIL ARABINOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; SUICIDE GENE; ANIMAL; CELL STRAIN HT29; ENZYMOLOGY; HERPES SIMPLEX VIRUS 1; METABOLISM; METHODOLOGY; SYNTHESIS;

ANIMALS; ARABINOFURANOSYLURACIL; FLUORINE RADIOISOTOPES; FLUOROURACIL; GENE EXPRESSION; HERPESVIRUS 1, HUMAN; HT29 CELLS; HUMANS; MICE; POSITRON-EMISSION TOMOGRAPHY; THYMIDINE KINASE;

EID: 16644366895     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Urbain JC. Reporter genes and imagene. J Nucl Med. 2001;42:106-109.
2. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 1999;96:2333-2338.
3. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. Assays for non-invasive imaging of reporter gene expression. Nucl Med Biol. 1999;26:481-490.
4. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998;58:4333-4341.
5. Tjuvajev JG, Chen SH, Joshi A, et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 1999;59:5186-5193.
6. Culver KW, Ram Z, Wallbridge S, Ishi H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
7. Moolten FL, Wells JM, Heyman RA, Evans RM. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther. 1990;1:125-134.
8. Oldfield EH, Ram Z, Culver K, Blease RM, DeVroom HL, Anderson WF. Clinical protocols: gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther. 1993;4:39-69.
9. Ram Z, Culver KW, Oshireo EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med. 1997;3:1353-1361.
10. Jacobs A, Tjuvajev JG, Dubrovin M, et al. Positron emission tomography-based imaging of transgene expression mediated by replication conditional, oncolytic herpes simplex virus type-1 mutant vectors of cancer. Cancer Res. 2001;61:2983-2995.
11. 18F]-FHBG) as a probe for PET imaging of gene expression in tumor-bearing nude mice. Anticancer Res. 1998;18:4992-4993.
12. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 1999;26:371-376.
13. Haberkorn U, Altmann A, Morr I, et al. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med. 1997;38:287-294.
14. Yu Y, Annala AJ, Barrio JR, et al. Quantification of gene expression by imaging reporter gene expression in living animals. Nat Med. 2000;6:933-937.
15. Tjuvajev JG, Stockhammar G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res. 1995;55:6126-6132.
16. Barrio JR, Namavari M, Satyamurthy N, et al. 8-[F-18]Fluoroacyclovir: an in vivo probe for gene expression with PET [abstract]. J Nucl Med. 1996;37(suppl):193P.
17. 18F]- Fluoropenciclovir: an improved reporter probe for imaging HSV-tk reporter gene expression in vivo using PET. J Nucl Med. 2001;42:96-105.
18. Spadari S, Maga G, Focher F, et al. L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem. 1992;35:4214-4220.
19. Watenabe KA, Richmond W, Hirota K, Lopez C, Fox JJ. Nucleosides 110: synthesis and herpes virus activity of some 2′-fluoro-2′- deoxyarabinofuranosyl pyrimidine nucleosides. J Med Chem. 1979;22:21-24.
20. 18F]FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol. 1996;23:787-792.
21. 18F]-FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998;25:175-180.
22. 18F]-FHBG) for in vivo measurement of suicide gene expression with PET. J Nucl Med. 2001;42:1682-1690.
23. 2: a facile entry for 8-fluorguanine derivatives. J Org Chem. 1996;61:6084-6085.
24. 18F]-fluoroguanine derivatives: in vivo probes for imaging gene expression with PET. Nucl Med Biol. 2000;27:157-162.
25. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2′-deoxy-2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002;1:74-81.
26. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Direct comparison of HSV-tk PET imaging probes: FIAU, FHPG, FHBG. J Nucl Med. 2002;43:1072-1083.
27. 18F]FFAU) for PET imaging studies. Paper presented at: 213th American Chemical Society National Conference; April 25-29, 1997; San Francisco, CA.
28. 18F]-FMAU). J Labelled Compds Radiopharm. 2002;45:583-590.
29. 18F]fluoro-5-methyl-1-β-D- arabinofuranosyluracil and its 5-substituted nucleosides. J Labelled Compds Radiopharm. 2003;46:285-289.
30. Lyons RM, Forry-Schaudies S, Otto E, et al. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increasing antitumor efficacy in vivo. Cancer Gene Ther. 1995;2:273-280.
31. Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D. Mechanism for ganciclovir resistance in gastrointestinal tumor cells transduced with retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin Cancer Res. 1998;4:731-741.
32. Coderre JA, Santi DV, Mysuda A, Watenabe KA, Fox JJ. Mechanism of action of 2′-5-difluoro-1-arabinofuranosyluracil. J Med Chem. 1983;26:1149-1152.